Yanyu Wang - Concepedia

Author

Yanyu Wang

Peking Union Medical College Hospital ORCID

Also Known As

Wang, Yanyu, Yan-Yu Wang, Yanyu Wang, Yanyu Wang (1945624)

Publications

918

Citations

H-Index

Concepts

All Affiliations

Peking Union Medical College Hospital Chinese Academy of Medical Sciences & Peking Union Medical College Zhengzhou University Frederick National Laboratory for Cancer Research National Cancer Institute

About

Yanyu Wang is an author at Peking Union Medical College Hospital specializing in medicine, oncology, and pathology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	7	7	158
2	Health Sciences	2	2	56
3	Cell Biology	1	1	23
4	Hepatology	1	1	14
5	Immunology	1	1	12

Yanyu Wang

Publications

722

Citations

H-Index

Page 1

	Year	Citations
Characterization of HLH-like manifestations as a CRS variant in patients receiving CD22 CAR T cells Daniel A. Lichtenstein, Fiorella Schischlik, Lipei Shao, Blood	2021	173
Biomarkers and prognostic factors of PD-1/PD-L1 inhibitor-based therapy in patients with advanced hepatocellular carcinoma Nan Zhang, Yang Xu, Mingjian Piao, Biomarker Research	2024	72
The Efficacy and Safety of Apatinib Plus Camrelizumab in Patients With Previously Treated Advanced Biliary Tract Cancer: A Prospective Clinical Study Dongxu Wang, Xu Yang, Junyu Long, Frontiers in Oncology	2021	52
Distribution of ALK Fusion Variants and Correlation with Clinical Outcomes in Chinese Patients with Non-Small Cell Lung Cancer Treated with Crizotinib Yudong Su, Xiang Long, Yang Song, Targeted Oncology Health SciencesMedicinePathologyAlk Fusion VariantsBronchial Neoplasm	2019	42
Comparison of Baseline<sup>68</sup>Ga-FAPI and<sup>18</sup>F-FDG PET/CT for Prediction of Response and Clinical Outcome in Patients with Unresectable Hepatocellular Carcinoma Treated with PD-1 Inhibitor and Lenvatinib Meiqi Wu, Yanyu Wang, Qiao Yang, Journal of Nuclear Medicine	2023	42
Efficacy, safety, and prognostic factors of PD-1 inhibitors combined with lenvatinib and Gemox chemotherapy as first-line treatment in advanced intrahepatic cholangiocarcinoma: a multicenter real-world study Chengpei Zhu, Hu Li, Xiaobo Yang, Cancer Immunology Immunotherapy	2023	32
CD22 CAR T-cell associated hematologic toxicities, endothelial activation and relationship to neurotoxicity Jennifer Jess, Bonnie Yates, Alina Dulau‐Florea, Journal for ImmunoTherapy of Cancer	2023	32
Radiation Therapy With Combination Therapy of Immune Checkpoint Inhibitors and Antiangiogenic Therapy for Hepatocellular Carcinoma Ning Cong, Xinmu Zhang, Yanyu Wang, International Journal of Radiation OncologyBiologyPhysics	2023	29
4D-QSAR and MIA-QSAR study on the Bruton's tyrosine kinase (Btk) inhibitors Wenzhi Ma, Yanyu Wang, Dongchen Chu, Journal of Molecular Graphics and Modelling Medicinal ChemistryMedicineTyrosine KinaseReceptor Tyrosine KinaseMechanism Of Action	2019	27
The impact of resilience on anxiety and depression among grass-roots civil servants in China Huiling Song, Mengjie Zhang, Yanjie Wang, BMC Public Health	2021	27

Page 1